HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Has Selected Research

CC-90009

3/2024Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation.
1/2021Effect of small molecule eRF3 degraders on premature termination codon readthrough.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Has Research Topics

Disease

15Epidermolysis Bullosa
04/2024 - 04/2007
14Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
03/2024 - 12/2005
12Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
06/2023 - 03/2011
9Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
11/2023 - 08/2006
6Poikiloderma of Kindler
06/2017 - 01/2004
5Inflammation (Inflammations)
03/2024 - 04/2011
5Inborn Genetic Diseases (Disease, Hereditary)
03/2024 - 07/2014
5Wounds and Injuries (Trauma)
03/2024 - 01/2017
4Ichthyosis (Xeroderma)
05/2024 - 01/2015
4Skin Diseases (Skin Disease)
03/2024 - 04/2012
4Neoplasms (Cancer)
01/2024 - 02/2016
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2024 - 01/2019
3Nephrotic Syndrome (Syndrome, Nephrotic)
12/2018 - 07/2015
3Interstitial Lung Diseases (Interstitial Lung Disease)
12/2018 - 07/2015
2Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)
05/2024 - 05/2014
2Bullous Pemphigoid (Pemphigoid)
11/2023 - 01/2017
2Skin Manifestations
10/2023 - 03/2014
2Disease Progression
06/2023 - 01/2022
2Incontinentia Pigmenti (Bloch Sulzberger Syndrome)
01/2022 - 11/2018
2Cardiomyopathies (Cardiomyopathy)
01/2022 - 03/2015
2Cicatrix (Scar)
01/2021 - 01/2019
2Blister (Bulla)
01/2019 - 12/2006
2Atrophy
01/2019 - 11/2011
2Fibrosis (Cirrhosis)
01/2018 - 04/2011
2Melanoma (Melanoma, Malignant)
06/2017 - 10/2009
2Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
03/2015 - 05/2011
2Skin Neoplasms (Skin Cancer)
01/2013 - 11/2011
1Epidermal Nevus
05/2024
1Oral Manifestations
03/2024
1Amelogenesis Imperfecta
03/2024
1Porokeratosis (Palmoplantar Porokeratosis)
10/2023
1Carcinoma (Carcinomatosis)
06/2023
1Darier Disease (Darier's Disease)
04/2023
1Benign Familial Pemphigus (Hailey Hailey Disease)
04/2023
1Lamellar Ichthyosis (Harlequin Ichthyosis)
04/2023
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2022
1Systemic Mastocytosis
12/2022
1Squamous Cell Neoplasms (Squamous Cell Cancer)
05/2022
1Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa)
01/2022
1Mucopolysaccharidosis I (Hurler Syndrome)
01/2021
1Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis)
01/2021
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2021
1Autosomal Recessive Epidermolysis Bullosa Simplex
10/2019
1Cysts
10/2019
1Ciliopathies
11/2018

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
11/2023 - 12/2006
7Collagen Type XVIIIBA
03/2024 - 12/2005
7IntegrinsIBA
11/2023 - 04/2012
6Nonsense Codon (Nonsense Mutation)IBA
03/2024 - 01/2004
5Keratins (Keratin)IBA
05/2024 - 04/2010
5CollagenIBA
01/2022 - 01/2018
3AntigensIBA
11/2023 - 01/2016
3RNA (Ribonucleic Acid)IBA
10/2023 - 01/2018
3Collagen Type VIIIBA
01/2019 - 03/2011
2dupilumabIBA
04/2024 - 04/2024
2CC-90009IBA
03/2024 - 01/2021
2Gentamicins (Gentamicin)FDA LinkGeneric
03/2024 - 01/2022
2AminoglycosidesIBA
03/2024 - 01/2021
2CytokinesIBA
10/2023 - 04/2011
2Interleukin-17 (Interleukin 17)IBA
10/2023 - 04/2023
2Keratin-5 (Keratin 5)IBA
10/2019 - 01/2019
2KalininIBA
11/2018 - 01/2013
2Keratin-14 (Keratin 14)IBA
05/2018 - 08/2006
2Amino AcidsFDA Link
01/2017 - 01/2017
2SteroidsIBA
03/2014 - 05/2002
2Glycine (Aminoacetic Acid)FDA LinkGeneric
03/2011 - 01/2006
1Immunoglobulin A (IgA)IBA
05/2024
1acetovanillone (apocynin)IBA
03/2024
1MelatoninIBA
03/2024
1Immune Checkpoint ProteinsIBA
01/2024
1EnzymesIBA
01/2024
1AutoantibodiesIBA
11/2023
1AutoantigensIBA
11/2023
1Laminin (Merosin)IBA
11/2023
1Cysteine (L-Cysteine)FDA Link
11/2023
1Interleukin-5 (Interleukin 5)IBA
10/2023
1LigandsIBA
06/2023
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2023
1Apoptosis Regulatory ProteinsIBA
06/2023
1Biomarkers (Surrogate Marker)IBA
06/2023
1InterleukinsIBA
04/2023
1Keratin-2 (Keratin 2)IBA
04/2023
1Phosphotransferases (Kinase)IBA
12/2022
1midostaurinIBA
12/2022
1Ligases (Synthetase)IBA
01/2022
1UbiquitinIBA
01/2022
1amsonic acid (DAS)IBA
01/2022
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2022
1CC-885IBA
01/2021
1Phospholipase C deltaIBA
10/2019
1delta proteinIBA
10/2019
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
10/2019
1DNA (Deoxyribonucleic Acid)IBA
10/2019
12-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA
01/2019
1ON 01910IBA
01/2019

Therapy/Procedure

14Therapeutics
03/2024 - 11/2012
2Immunotherapy
01/2024 - 06/2023
2Precision Medicine
01/2018 - 01/2017
1Dental Care
03/2024
1Liver Transplantation
11/2018